 | • レポートコード：QYR9ST04411 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、セリアック病薬の世界市場について調査・分析し、セリアック病薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（第一線治療、第二線治療）、用途別（病院、研究）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のセリアック病薬市場動向 ・主要企業別マーケットシェア ・セリアック病薬の種類別市場規模2014-2019 （第一線治療、第二線治療） ・セリアック病薬の用途別市場規模2014-2019 （病院、研究） ・セリアック病薬の北米市場：主要企業・種類別/用途別市場規模 ・セリアック病薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・セリアック病薬の中国市場：主要企業・種類別/用途別市場規模 ・セリアック病薬の日本国内市場：主要企業・種類別/用途別市場規模 ・セリアック病薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・セリアック病薬のインド市場：主要企業・種類別/用途別市場規模 ・セリアック病薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche、Merck、Johnson & Johnson、BiolineRx、Pfizer、Innovate Biopharmaceuticals、ImmusanT、Novartis、Bristol-Myers Squibb Company、Immunomedics） ・セリアック病薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers. In 2018, the global Celiac Disease Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Celiac Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Celiac Disease Drugs development in United States, Europe and China.
The key players covered in this study
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb Company
Immunomedics
Market segment by Type, the product can be split into
First Line of Treatment
Second Line of Treatment
Market segment by Application, split into
Hospital
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Celiac Disease Drugs status, future forecast, growth opportunity, key market and key players.
To present the Celiac Disease Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Celiac Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Celiac Disease Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 First Line of Treatment
1.4.3 Second Line of Treatment
1.5 Market by Application
1.5.1 Global Celiac Disease Drugs Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Celiac Disease Drugs Market Size
2.2 Celiac Disease Drugs Growth Trends by Regions
2.2.1 Celiac Disease Drugs Market Size by Regions (2014-2025)
2.2.2 Celiac Disease Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Celiac Disease Drugs Market Size by Manufacturers
3.1.1 Global Celiac Disease Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Celiac Disease Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Celiac Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Celiac Disease Drugs Key Players Head office and Area Served
3.3 Key Players Celiac Disease Drugs Product/Solution/Service
3.4 Date of Enter into Celiac Disease Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Celiac Disease Drugs Market Size by Type (2014-2019)
4.2 Global Celiac Disease Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Celiac Disease Drugs Market Size (2014-2019)
5.2 Celiac Disease Drugs Key Players in United States
5.3 United States Celiac Disease Drugs Market Size by Type
5.4 United States Celiac Disease Drugs Market Size by Application
6 Europe
6.1 Europe Celiac Disease Drugs Market Size (2014-2019)
6.2 Celiac Disease Drugs Key Players in Europe
6.3 Europe Celiac Disease Drugs Market Size by Type
6.4 Europe Celiac Disease Drugs Market Size by Application
7 China
7.1 China Celiac Disease Drugs Market Size (2014-2019)
7.2 Celiac Disease Drugs Key Players in China
7.3 China Celiac Disease Drugs Market Size by Type
7.4 China Celiac Disease Drugs Market Size by Application
8 Japan
8.1 Japan Celiac Disease Drugs Market Size (2014-2019)
8.2 Celiac Disease Drugs Key Players in Japan
8.3 Japan Celiac Disease Drugs Market Size by Type
8.4 Japan Celiac Disease Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Celiac Disease Drugs Market Size (2014-2019)
9.2 Celiac Disease Drugs Key Players in Southeast Asia
9.3 Southeast Asia Celiac Disease Drugs Market Size by Type
9.4 Southeast Asia Celiac Disease Drugs Market Size by Application
10 India
10.1 India Celiac Disease Drugs Market Size (2014-2019)
10.2 Celiac Disease Drugs Key Players in India
10.3 India Celiac Disease Drugs Market Size by Type
10.4 India Celiac Disease Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Celiac Disease Drugs Market Size (2014-2019)
11.2 Celiac Disease Drugs Key Players in Central & South America
11.3 Central & South America Celiac Disease Drugs Market Size by Type
11.4 Central & South America Celiac Disease Drugs Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Celiac Disease Drugs Introduction
12.1.4 Roche Revenue in Celiac Disease Drugs Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Celiac Disease Drugs Introduction
12.2.4 Merck Revenue in Celiac Disease Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Celiac Disease Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Celiac Disease Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 BiolineRx
12.4.1 BiolineRx Company Details
12.4.2 Company Description and Business Overview
12.4.3 Celiac Disease Drugs Introduction
12.4.4 BiolineRx Revenue in Celiac Disease Drugs Business (2014-2019)
12.4.5 BiolineRx Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Celiac Disease Drugs Introduction
12.5.4 Pfizer Revenue in Celiac Disease Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Innovate Biopharmaceuticals
12.6.1 Innovate Biopharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Celiac Disease Drugs Introduction
12.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2014-2019)
12.6.5 Innovate Biopharmaceuticals Recent Development
12.7 ImmusanT
12.7.1 ImmusanT Company Details
12.7.2 Company Description and Business Overview
12.7.3 Celiac Disease Drugs Introduction
12.7.4 ImmusanT Revenue in Celiac Disease Drugs Business (2014-2019)
12.7.5 ImmusanT Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Celiac Disease Drugs Introduction
12.8.4 Novartis Revenue in Celiac Disease Drugs Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Bristol-Myers Squibb Company
12.9.1 Bristol-Myers Squibb Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Celiac Disease Drugs Introduction
12.9.4 Bristol-Myers Squibb Company Revenue in Celiac Disease Drugs Business (2014-2019)
12.9.5 Bristol-Myers Squibb Company Recent Development
12.10 Immunomedics
12.10.1 Immunomedics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Celiac Disease Drugs Introduction
12.10.4 Immunomedics Revenue in Celiac Disease Drugs Business (2014-2019)
12.10.5 Immunomedics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Celiac Disease Drugs Key Market Segments
Table Key Players Celiac Disease Drugs Covered
Table Global Celiac Disease Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Celiac Disease Drugs Market Size Market Share by Type 2014-2025
Figure First Line of Treatment Figures
Table Key Players of First Line of Treatment
Figure Second Line of Treatment Figures
Table Key Players of Second Line of Treatment
Table Global Celiac Disease Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Research Case Studies
Figure Celiac Disease Drugs Report Years Considered
Table Global Celiac Disease Drugs Market Size 2014-2025 (Million US$)
Figure Global Celiac Disease Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Celiac Disease Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Celiac Disease Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Celiac Disease Drugs Market Share by Regions 2014-2019
Figure Global Celiac Disease Drugs Market Share by Regions 2014-2019
Figure Global Celiac Disease Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Celiac Disease Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Celiac Disease Drugs Market Share by Manufacturers (2014-2019)
Figure Global Celiac Disease Drugs Market Share by Manufacturers in 2018
Table Global Celiac Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Celiac Disease Drugs Product/Solution/Service
Table Date of Enter into Celiac Disease Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Celiac Disease Drugs Market Size Share by Type (2014-2019)
Figure Global Celiac Disease Drugs Market Size Market Share by Type (2014-2019)
Table Global Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Celiac Disease Drugs Market Size Share by Application (2014-2019)
Figure Global Celiac Disease Drugs Market Size Market Share by Application (2014-2019)
Figure Global Celiac Disease Drugs Revenue Market Share by Application in 2018
Figure United States Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Celiac Disease Drugs Market Share (2018-2019)
Table United States Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Celiac Disease Drugs Market Share by Type (2014-2019)
Table United States Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Celiac Disease Drugs Market Share by Application (2014-2019)
Figure Europe Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Celiac Disease Drugs Market Share (2018-2019)
Table Europe Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Celiac Disease Drugs Market Share by Type (2014-2019)
Table Europe Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Celiac Disease Drugs Market Share by Application (2014-2019)
Figure China Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Celiac Disease Drugs Market Share (2018-2019)
Table China Celiac Disease Drugs Market Size by Type (2014-20189) (Million US$)
Table China Celiac Disease Drugs Market Share by Type (2014-2019)
Table China Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table China Celiac Disease Drugs Market Share by Application (2014-2019)
Figure Japan Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Celiac Disease Drugs Market Share (2018-2019)
Table Japan Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Celiac Disease Drugs Market Share by Type (2014-2019)
Table Japan Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Celiac Disease Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Celiac Disease Drugs Market Share (2018-2019)
Table Southeast Asia Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Celiac Disease Drugs Market Share by Type (2014-2019)
Table Southeast Asia Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Celiac Disease Drugs Market Share by Application (2014-2019)
Figure India Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Celiac Disease Drugs Market Share (2018-2019)
Table India Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table India Celiac Disease Drugs Market Share by Type (2014-2019)
Table India Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table India Celiac Disease Drugs Market Share by Application (2014-2019)
Figure Central & South America Celiac Disease Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Celiac Disease Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Celiac Disease Drugs Market Share (2018-2019)
Table Central & South America Celiac Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Celiac Disease Drugs Market Share by Type (2014-2019)
Table Central & South America Celiac Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Celiac Disease Drugs Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Celiac Disease Drugs Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Merck Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table BiolineRx Company Details
Table BiolineRx Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure BiolineRx Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table BiolineRx Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Innovate Biopharmaceuticals Company Details
Table Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Innovate Biopharmaceuticals Recent Development
Table ImmusanT Company Details
Table ImmusanT Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure ImmusanT Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table ImmusanT Recent Development
Table Novartis Company Details
Table Novartis Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Immunomedics Company Details
Table Immunomedics Revenue in Celiac Disease Drugs Business (2014-2019)(Million US$)
Figure Immunomedics Revenue Growth Rate in Celiac Disease Drugs Business (2014-2019)
Table Immunomedics Recent Development
Table Global Celiac Disease Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Celiac Disease Drugs Market Size Share by Regions (2019-2025)
Figure Global Celiac Disease Drugs Market Size Share by Regions in 2025
Figure United States Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Celiac Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Celiac Disease Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Celiac Disease Drugs Market Size by Product (2019-2025)
Figure Global Celiac Disease Drugs Market Size by Product in 2025
Table Global Celiac Disease Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Celiac Disease Drugs Market Size by Application (2019-2025)
Figure Global Celiac Disease Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
セリアック病の世界市場：インサイト・予測 Celiac disease is a serious autoimmune disorder that can occur in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. It is estimated to affect 1 in 100 people worldwide.The global Celiac Disease market is valued at 130 million US$ in 2018 and will re…- クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- 感染症治療の世界市場：市場規模・現状・予測 Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.In 2018, the global Infectious Disease Treatment market size was xx …
- 重症筋無力症薬の世界市場：市場規模・現状・予測 Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …